Holen Sie sich die Stockscreener-App
15.88
7.94%
-1.37
Handel nachbörslich:
15.82
-0.06
-0.38%
Schlusskurs vom Vortag:
$17.25
Offen:
$17.15
24-Stunden-Volumen:
1.65M
Relative Volume:
1.19
Marktkapitalisierung:
$1.08B
Einnahmen:
$2.73B
Nettoeinkommen (Verlust:
$-1.13B
KGV:
-0.9531
EPS:
-16.6622
Netto-Cashflow:
$-83.00M
1W Leistung:
+4.06%
1M Leistung:
-23.76%
6M Leistung:
-46.35%
1J Leistung:
-43.55%
1-Tages-Spanne:
$15.71
$17.35
1-Wochen-Bereich:
$15.55
$17.55
52-Wochen-Spanne:
$14.45
$38.99
Quidelortho Corporation Stock (QDEL) Company Profile
Firmenname
Quidelortho Corporation
Sektor
Branche
Telefon
(858) 552-1100
Adresse
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA
Compare QDEL vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QDEL
Quidelortho Corporation
|
15.88 | 1.17B | 2.73B | -1.13B | -83.00M | -16.66 |
ABT
Abbott Laboratories
|
102.30 | 178.75B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
332.30 | 126.97B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.28 | 111.22B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
62.59 | 93.36B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.19 | 46.73B | 6.07B | 1.06B | 1.34B | 1.8063 |
Quidelortho Corporation Stock (QDEL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-07 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-05-08 | Hochstufung | Jefferies | Hold → Buy |
| 2024-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-12-10 | Eingeleitet | Jefferies | Hold |
| 2024-09-19 | Fortgesetzt | UBS | Neutral |
| 2024-09-05 | Hochstufung | Craig Hallum | Hold → Buy |
| 2024-03-04 | Herabstufung | UBS | Neutral → Sell |
| 2024-02-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-12-11 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-14 | Hochstufung | UBS | Sell → Neutral |
| 2022-09-19 | Eingeleitet | Citigroup | Neutral |
| 2022-07-20 | Eingeleitet | UBS | Sell |
| 2022-06-17 | Fortgesetzt | JP Morgan | Neutral |
| 2022-02-22 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2021-01-22 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-05-12 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2020-03-26 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2018-10-23 | Fortgesetzt | Raymond James | Strong Buy |
| 2018-03-08 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2018-01-22 | Bestätigt | Barclays | Overweight |
| 2018-01-04 | Hochstufung | CL King | Neutral → Buy |
| 2017-09-19 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2017-07-18 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2017-07-18 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2017-04-25 | Bestätigt | Canaccord Genuity | Hold |
| 2017-02-17 | Eingeleitet | CL King | Neutral |
| 2016-12-16 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2016-06-13 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2016-02-18 | Bestätigt | Barclays | Overweight |
| 2016-02-09 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2016-01-08 | Bestätigt | Canaccord Genuity | Buy |
| 2015-12-14 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-09-02 | Eingeleitet | Barclays | Overweight |
| 2013-07-31 | Bestätigt | Canaccord Genuity | Buy |
| 2011-03-03 | Herabstufung | Wedbush | Outperform → Neutral |
Alle ansehen
Quidelortho Corporation Aktie (QDEL) Neueste Nachrichten
Guardant Health, Organon, Fortrea, QuidelOrtho, and Charles River Laboratories Stocks Trade Down, What You Need To Know - TradingView
QuidelOrtho (NASDAQ:QDEL) Shares Down 3.6%Should You Sell? - marketbeat.com
QuidelOrtho Corporation (QDEL) Stock Price, News, Quote & History - Yahoo! Finance Canada
QuidelOrtho Corporation (QDEL) stock price, news, quote and history - Yahoo Finance Australia
QuidelOrtho Corporation $QDEL Shares Sold by JPMorgan Chase & Co. - MarketBeat
QuidelOrtho (NASDAQ:QDEL) Rating Increased to Buy at Wall Street Zen - marketbeat.com
Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell shares are falling, what you need to know - MSN
QuidelOrtho Corp Stock: Navigating Diagnostics Leadership Amid Sector Evolution and Investor Opportu - AD HOC NEWS
Aug Final Week: Is QuidelOrtho Corporation a defensive stock2026 Trading Volume Trends & Accurate Buy Signal Alerts - baoquankhu1.vn
Buyback Watch: Why is QuidelOrtho Corporation stock going downWeekly Trend Report & Real-Time Price Movement Reports - baoquankhu1.vn
QuidelOrtho Corporation (QDEL) Stock forecasts - Yahoo Finance UK
QuidelOrtho Corp. Stock Plummets to New 52-Week Low of $14.45 - Markets Mojo
How does QuidelOrtho Corporation compare to its peers2026 Drop Watch & Fast Entry Momentum Alerts - baoquankhu1.vn
Value Recap: Does QuidelOrtho Corporation offer margin of safetyMarket Growth Report & Verified Stock Trade Ideas - baoquankhu1.vn
QuidelOrtho Corp. Stock Plummets to New 52-Week Low of $17.08 - Markets Mojo
Precision Trading with Quidelortho Corp Com (QDEL) Risk Zones - Stock Traders Daily
Align Technology, QuidelOrtho, DexCom, Insulet, and Omnicell Shares Are Falling, What You Need To Know - Yahoo Finance
Vanguard disaggregates holdings; reports 0 shares of QuidelOrtho (QDEL) - Stock Titan
QuidelOrtho (NASDAQ:QDEL) Reaches New 12-Month LowHere's What Happened - MarketBeat
Why is QuidelOrtho (QDEL) down 24.5% since last earnings report? - MSN
QuidelOrtho Corporation (QDEL) Stock Forecasts - Yahoo Finance
QuidelOrtho Corporation (NASDAQ:QDEL) Given Average Recommendation of "Reduce" by Brokerages - marketbeat.com
Medtech business QuidelOrtho hires STAAR Surgical legal head as CLO - The Global Legal Post
QuidelOrtho names Nathaniel Sisitsky as chief legal officer By Investing.com - Investing.com Australia
Nathaniel Sisitsky Joins QuidelOrtho as Chief Legal Officer - Sahm
QuidelOrtho (QDEL) Welcomes New Chief Legal Officer - GuruFocus
QuidelOrtho Announces Chief Legal Officer Leadership Transition - TipRanks
In Vitro Diagnostics Firm QuidelOrtho Picks New Legal Chief - Bloomberg Law News
QuidelOrtho Corporation Announces Chief Legal Officer Changes - marketscreener.com
QuidelOrtho names Nathaniel Sisitsky as chief legal officer - investing.com
QuidelOrtho Corp. Hits Day Low of $16.16 Amid Price Pressure - Markets Mojo
QDEL SEC FilingsQuidel 10-K, 10-Q, 8-K Forms - Stock Titan
QuidelOrtho (NASDAQ:QDEL) Stock Price Up 9.5%What's Next? - MarketBeat
QuidelOrtho Corp. Stock Plummets to New 52-Week Low at $15.08 - Markets Mojo
QuidelOrtho(QDEL) Soars 8.79% on Intraday Surge: Is This a Breakout or a Flash in the Pan? - Bitget
QuidelOrtho (QDEL) 43rd Annual J.P. Morgan Healthcare Conference 2025 Summary - Quartr
QuidelOrtho (QDEL) Morgan Stanley’s 22nd Annual Global Healthcare Conference summary - Quartr
QuidelOrtho (QDEL) Baird 2024 Global Healthcare Conference Summary - Quartr
Risk Report: Is QuidelOrtho Corporation stock technically oversold2026 Rallies & Weekly Breakout Watchlists - baoquankhu1.vn
QuidelOrtho Corp stock hits new 52-week low amid persistent financial struggles and biotech sector h - AD HOC NEWS
QuidelOrtho Corp. Hits New 52-Week Low at $16.16 Amid Ongoing Struggles - Markets Mojo
QuidelOrtho Corp. Hits Day High with Strong 8.33% Intraday Surge - Markets Mojo
QuidelOrtho (NASDAQ:QDEL) Sets New 12-Month LowTime to Sell? - MarketBeat
QuidelOrtho Corp. Stock Plummets to New 52-Week Low at $17.03 - Markets Mojo
QuidelOrtho Corp. Hits Day Low at $17.03 Amid Price Pressure - Markets Mojo
RBC Capital Raises PT on QuidelOrtho Corporation From $60 to $62, Keeps Buy Rating - MSN
QuidelOrtho (NASDAQ:QDEL) Trading Down 8.3%Should You Sell? - MarketBeat
QuidelOrtho Plunges 9.6%: A Bearish Flash in the Healthcare Sector - Bitget
QuidelOrtho (NASDAQ:QDEL) Trading 9.3% HigherHere's What Happened - MarketBeat
EPS Watch: Is QuidelOrtho Corporation a turnaround story2026 Outlook & Reliable Entry Point Alerts - baoquankhu1.vn
Finanzdaten der Quidelortho Corporation-Aktie (QDEL)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):